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Abstract
Cryoprotectants are basically some chemical compounds which prevent cells or tissues 
from damage due to freezing. Mostly vitrification and thawing process are mostly used 
in cryopreservation. Now a day’s cryopreservation is becoming an apex technology for 
Health sector, as many organ and tissue transplant methods has been developed in recent 
time. Organs or tissues need to preserve properly before implantation, hence cryopro-
tectants plays a key role modern cryonics. This article seeks to provide answers for how 
cryoprotectants works and prevent tissue damage from shrinking ice crystals during 
freeze drying or vitrification. The various animal tissues, organs, lymphocytes, cartilages, 
bone marrow, proteins can be stored by using proper cryoprotectants. Optimization of 
cryoprotectants is a challenging task, as elevated concentration may cause cytotoxicity. 
This article also highlights the implication, challenges and recent advances of cryoprotec-
tants along with its types. The importance of cryobank system and its importance were 
also being emphasized in this article. Further, importance of cryoprotectants in nano 
suspension preparation was also been discussed in this article.
Keywords: cryopreservation, vitrification, cryoprotectants, cryobank system, dimethyl 
sulfoxide, glycerol
1. Introduction
To prevent cell death during preservation, tissues and organs temperature used to lower to 
stop cell death. But at the same time rate of cooling also affect the cell survival. The preserv-
ing cells which are cools quickly are susceptible for cell death due to rapid intracellular ice 
formation. Sometimes due to dehydration, cells can die. In other way, due to the presence 
of hypotonic solutions surrounding of cells can also leads to cell shrinking and cell death. 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The deleterious affect associated with slow drying was sorted out by using glycerol as cryo-
protectant during 1949. Without proper cryoprotectant cells ruptures due to “Solution effect” 
injury; in which residual solution of cells altars shape, mechanical strength of the cells fol-
lowed by osmatic oscillation during freeze drying. What basically cryoprotectants do is after 
dissolving in preserving solution it lowers the melting point of the solution so that tissue or 
organs can freeze within its surroundings but not within its cells [1]. These cryoprotectants 
are sometime called as antifreeze. There are so many cryoprotectants but glycerol, propylene 
glycol, dimethyl sulfoxide (DMSO) are most commonly used within this category. For the 
cell survival after freezing and thawing of liquid nitrogen temperature, it became necessary 
to preserve tissues with suitable cryoprotectant (5–15%) which helps to form large unfreeze 
pockets [2]. These pockets helps to prevent crystal formation and mechanical damage. During 
freeze drying process organs and tissues are venerable to freezing injury, for any organ to re-
established function after freeze drying has to have intact parenchymal cell to cell of small 
blood vessels. Only 25% of cell survival during freeze drying is not enough, hence a new 
approach of tissue preservation called vitrification is required to protect tissues. Vitrification 
means turns into a glass. Fathy, advocated vitrification, in which tissue or organ encircled 
into unfrozen glassy pocket containing cryoprotectant, it was planned, tissues to be treated 
with maximum cryoprotectant before freeze drying to avoid ice formation [3]. Due to the 
rapid acceptance of verification and slow freezing process, a maximum number of animal 
germ plasmas, tissues were started to store by these process. Further advancement embarks 
the idea to preserve tissues below −130 to −196°C, which is basically a sub-zero temperature 
using some substances. It was also observed that all the associated problems of refrigerating 
storage such as integrity of living cells while storing, freezing injury, forming ice crystals 
which eventually damage stored cells, could be restricted from using such substance. These 
substances are also helping in moisturizing the living cells by penetrating inside of stored 
cells without altering or creating any lethal effect to those cells, such substances are called 
as the cryoprotectants or the cryopreservatives. Without cryoprotectants at low-temperature 
biological cells damaged, and at in transition phase such as changes from frozen solid to a 
liquid by a general warming, cells loses numbness and stiffness, this condition is called thaw-
ing. Mostly slow freezing is preferable for preserving cells in which cells are frizzed slowly 
below its freezing point, but at a certain point, the formation of spherical crystals can destroy 
cells chronobiology. These crystals are called as unfrozen fractions [5]. Using cryoprotectants 
along with some electrolytes and sugars it is possible to increase osmatic strength of the 
solvent by which positive efflux of moisture towards the cells occur and during this process 
chances of intercellular ice, the formation becomes negligible. Farther cooling causes increase 
of viscosity and due to this, chances of formations of ice crystals would become very infinitesi-
mal. In the last stage of slow cooling, remaining unfrozen fraction transformed to amorphous 
solids without ice crystals. The main objective of cryopreservation is to create a dehydrating 
environment for preserving cells. In this process cytosol observed less injury during cold 
freezing within liquid nitrogen, as numbers of crystalline substances formation would be 
very minimal. Mostly it was found that cryoinjuries occur during anomaly of instantaneous 
super freezing of cells. Slow freezing’s with lucid cryoprotectants causes fewer injuries [6]. 
Eventually, cryoinjuries occurs during pre-freezing and post-thawing, within the tempera-
ture of 0–40°C. During cryopreservation technique, pH, osmotic pressure, and concentration 
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of cryoprotectant has to be maintained, as elevation can cause cytoinjuries. In some cases, if 
the cell cytosol contains specific fatty acids, i.e., spermatozoa plasma membrane, it helps to 
maintain proper osmotic pressure and resist shock during thawing and freezing, by which 
fatty acids helps to maintain cells rehydration.
2. Toxicity due to cryoprotectant
During cryopreservation process using vitrification or freezing, almost half of the cell fluids 
were replaced with cryoprotectant molecules. These cryoprotectant molecules some time 
cause toxicity while in warm temperature. For example as a cryoprotectant in warm condition, 
propylene glycol is nontoxic while ethylene glycol metabolized to toxic elements. Recently it 
was found that lipophilicity of cryoprotectant could help in deeper penetration of cryopro-
tectant into cells causes destabilization of cells. On the other hand, strong hydrogen bonding 
also correlates with toxicity by disrupting the hydration shell around macromolecules. The 
electrical properties of cryoprotectant solution also has membrane toxicity. Among all cryo-
protectants, DMSO is severely toxic, basically DMSO/formamide solution has been useful in 
vitrification process, but mechanism of biomedical toxicity reduction is still unknown [1, 4].
3. Various components of cryoprotectant solution
Cryoprotectants solution may be a freezing solution or sometimes it may be a carrier solu-
tion. The carrier solution should not be an explicit cryoprotectant. Carrier solution helps to 
provide minimum support for cells at freezing temperature. Carrier solution often comprise 
of nutritional salts, buffers, osmogens, and apoptosis inhibitors. Often ingredients maintains 
isotonic concentration (300 milliosmoles) so that cells neither swells nor shrink when held 
in carrier solutions. These carrier solutions sometimes called as “base perfusate” solution. 
Carrier solution consisting of M22 cryoprotectants is called as LM5. During the process of 
freezing the carrier solution concentration always remains constant. Like carrier cryoprotec-
tants there is another type of cryoprotectants called penetrating cryoprotectants, the basic 
role of penetrating cryoprotectants is to reduce cell dehydration and ice growth. The pen-
etrating cryoprotectants are the major ingredients of vitrification solutions. Certain large 
molecular polymers are also been added to cryoprotectant solutions, they literally inhibits 
ice growth using same mechanism of penetrating cryoprotectants, these are called as Non-
penetrating cryoprotectants. Polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG) are 
examples of non-penetrating cryoprotectants. These cryoprotectants are highly toxic as com-
pare to penetrating cryoprotectants in same concentration. Recently it was discovered that 
non-penetrating cryoprotectants can increase tonicity of vitrification solutions, which helps 
to prevent chilling injury.
Some ingredients in cryoprotectants solution called ice blockers, which are helping directly to 
block ice growth. Some examples are polyglycerol, polyvinyl alcohol, X-1000 and Z-1000. Ice 
blockers are used only in vitrification solution [4, 6–8].
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3.1. Utilization of cryoprotectants
During cryopreservation, initially nearly 10% cryoprotectants were added in a single step. 
This causes classic shrink swell response of cryobiology, in which cells first shrink due to 
osmosis and later swell by penetrating cryoprotectants enters the cell. Unless and until cryo-
protectants volumes equals between intra cellular and extra cellular fluids of cells swelling 
persist. Within 10 min of concentration and volume adjustment, cell or tissue is ready for 
freezing. The cooling process is done very slowly, mostly less than 1°C/min. The addition 
of vitrification solutions during cryopreservation should not be exist 50% in a single steps, 
because of elevated osmatic shrinking response. The material’s which need to be vitrified 
exposed to several cryoprotectant solutions such as 1/8×, 1/4×, 1/2×, 1× full concentration vit-
rification solution as specially for 20 min each steps. During vitrification cooling and rewarm-
ing are done rapidly. During this process cryoprotectant solutions just perfused through cells 
like blood flow in blood vessels. After vitrification, cryoprotectant can be remove by reversing 
the steps describe earlier [9–13].
4. Mechanism of cryopreservation
The melting point of water decreases after proper mixing with suitable cryoprotectant. The 
various anti-freezing cryoprotectants are dimethyl sulfoxide (DMSO), propylene glycol. 
During freezing and thawing of isolated cells mostly 5–15% concentration of cryoprotectant 
concentration has to be maintained for better result. With cryoprotectant the freezing of cells 
in liquid nitrogen would be slower, further formation of relatively large vesicles and fewer 
salt crystals helps to protect cells from any mechanical injuries. As per evidence cryoprotec-
tants usually do not forms any hydrates and they are relatively less toxic to cells in elevated 
concentration. Vast expensive use of glycerol as cryoprotectants becomes a stepping stone 
towards finding more than hundred more cryoprotectants within 50 years. In new age pen-
etrating cryoprotectants were using vastly in the pharmaceutical industry because they are 
having a molecular mass of fewer than 100 Da and they penetrate inside of the cells and 
maintain moisture during freeze drying [4, 9].
5. Some common cryoprotectants used in pharmaceutical 
preservation
5.1. Dimethyl sulfoxide (DMSO)
The Great Russian scientist Alexander Zaytsevin on 1866 synthesized DMSO [4]. Basically 
DMSO is an organosulfur compound with the formula (CH
3
)
2
SO. It is also a polar aprotic 
solvent which can dissolve polar and nonpolar compounds and can be easily miscible with 
wide range of organic solvents and with water. DMSO has low cost and minor cytotoxicity, 
which makes it more prominent candidate for cryopreservation. It has garlic like taste. At any 
particular temperature, DMSO reduces the electrolytic concentration in the residual chilled 
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contents in and around of a biological cell, during cryopreservation. However rising of altered 
demarcated cells due to DNA methylation and histone alteration is a drawback of DMSO 
based cryopreservation. DMSO has typical property; it freezes within 18.5°C. This means, 
below room temperature DMSO transformed into solids, and this property makes it most 
suitable for cryoprotectant.
5.2. Ethylene glycol
Voelkel et al. [27] used 1.5 M ethylene glycol as a cryoprotectant for bovine embryols allow-
ing direct transfer of frozen-thawed embryos to recipient females. Ethylene glycol alters the 
hydrogen bonding when it mix with water. Purified ethylene glycol has a freezing point at 
about −12°C, but after mixing with 40% water and 60% ethylene glycol the freezing point 
of the mixture would depressed and mixture becomes incapable of forming crystalline sub-
stances. This condition leads to transformed freezing point at −45°C. This property of eth-
ylene glycol makes it the most effective candidate for cryoprotection. But some toxicity was 
observed for ethylene glycol, like GI irritation, pulmonary edema, and lung inflammation.
5.3. Glycerol
Oana Lelia Pop et al. [28] studied the effect of glycerol as cryoprotectant during freeze drying 
of microspheres containing probiotic cells. The colorless, the odorless viscous liquid of simple 
polyol (sugar alcohol) compound named as glycerol or glycerine. Glycerol has good kos-
motropic properties; it forms hydrogen bonds with water molecules. This condition makes 
difficult to form ice crystals by mixture (70% glycerol and 30% water), unless and until the 
temperature is very low such as −37.8°C. Compare to other cryoprotectant glycerol is less 
toxic in high concentration.
5.4. Propylene glycol
Propylene glycol IUPAC name is propane-1, 2-diol. It is basically a non-irritating synthetic 
organic compound with a chemical formula C
3
H
8
O
2
. It possess a fairly sweet taste with color 
less and odorless characteristics. Chemically it is a diol and miscible with water, chloroform, 
acetone. It is widely used as aircraft deicing fluid. Propylene glycol is sold under the name of 
RV or marine antifreeze. It also carries the property of automotive antifreeze.
5.5. 2-methyl-2, 4-pentanediol (MPD)
MPD widely used as precipitant, but in protein crystallography, it can be used as a cryopro-
tectant. It can be vividly used with polar and non-polar solvent. It can help the protein to 
precipitate.
5.6. Trehalose
This compound comprising with two molecules of glucose. Trehalose is otherwise called as 
mycose or tremalose. Due to its high water retaining properties it can be used as cryoprotectant. 
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Trehalose is less soluble than sucrose, except at high temperatures (>80°C). Trehalose forms 
rhomboid crystals of 90% calorific sucrose. The anhydrous forms of trehalose readily regain 
moisture to form the dehydrate. Trehalose improves cell survival after thawing compared 
with the standard freezing procedure. Sometimes trehalose can be used along with hyal-
uronic acid to treat dry eye.
5.7. The cell bank series
The cell banker series containing cryoprotectants media has 10% DMSO, a specific polymer, 
pH modifiers, glucose, bovine serum albumin. This combined cryopreservatives are used to 
preserve mammalian cells. This techniques allows rapid cell cryopreservation at −80°C and 
mean survival rate of cells after freezing and thawing was outstanding.
5.8. Formamide
It is also known as methanamide. It is derived from formic acid. It has ammonia like odder 
and clearly miscible with water. As a cryoprotectant, it helps to soften tissue vessels. It is also 
been used as a resins and plasticizer. The most common formamide is called as dimethylfor-
mamide, (CH
3
)
2
NCHO.
5.9. Glycerol 3-phosphate
This chemical compound comprising of glycerophospholipids. This product is also called as 
3-O-phosphonoglycerol.
5.10. Proline
Proline catalyzes aldol condensation. l-Proline is an osmoprotectant and therefore it has ver-
satile use in Pharmaceutical and Biotechnological applications. Proline is actively participat-
ing in biosynthesis of protein. Proline has α-amino group, a α-carboxylic group, pyrrolidine 
side chain, aliphatic amino acid group.
5.11. Sorbitol
Sorbitol is otherwise called as glucitol. The best part of sorbitol is, its get metabolize in tissue 
very slowly. During reduction of glucose aldehyde group reduced to hydroxyl group. Mostly 
sorbitol is prepared from corn syrup. Basically sorbitol is an isomer of mannitol. Apart from 
good cryoprotectant property sorbitol also used for hyperkalemia.
5.12. Diethyl glycol
It is an organic compound with a formula (HOCH
2
CH
2
)
2
O. It is colorless and odorless poi-
sonous hygroscopic compound. It is miscible with water, alcohol, acetone and ethylene gly-
col. Diethyl glycol is produce by partial hydrolysis of ethylene oxide. The dilute solution of 
diethyl glycol is a good cryoprotectant. A dilute solution of diethylene glycol can also be used 
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as a cryoprotectant; however, ethylene glycol is much more commonly used. Most ethylene 
glycol antifreeze contains a few percent diethylene glycol, present as a byproduct of ethylene 
glycol production.
5.13. Sucrose
Sucrose is actually naturally occurring carbohydrates sucrose in low temperature (−45°C), 
provides required nutrition to preserved cells, sucrose with the combination of DMSO main-
tains good cyroprotection properties.
5.14. Triethylene glycol
It is a colorless odorless viscous liquid with a molecular formula as HOCH
2
CH
2
OCH
2
CH
2
OCH
2
 
CH
2
O.
5.15. Polymers
It is possible to trauma biological materials using selective cryoprotective agents. Among all 
encapsulating materials, non-diffusible synthetic polymers can provide ridge cryoprotections 
of the biological cells within. For example polyvinyl alcohol, PEG, hydroxyethyl starch has 
good tendency to decrease the size of ice crystals.
6. Type of cryopreservation
6.1. Isochoric cryopreservation
Mostly all cryopreservation is based on an isobaric (constant pressure) process where freezing 
occurs at 1 atm pressure. But it has its own disadvantages, in this process intercellular ionic 
concentration increase, due to which chemical integrity changes within the cells during freez-
ing, which causes cell damage. But in the isochoric (constant volume) process the metabolic 
rate of frizzing constantly changing with every 10 degrees of temperature reduction. In the 
isochoric process, it is possible to store at absolute zero temperature and it helps to maintain 
cell integrity during slow frizzing [14].
6.2. Isobaric cryopreservation
Isobaric cryopreservation technique deals with the preservation of cells in one atmospheric 
pressure. This process is widely used, but the certain limitation of cyto cellular damage makes 
it more bizarre.
6.3. Hyperbaric cryopreservation
This cryopreservation method maintains low temperature (0°C) and high pressure followed 
by gradual demotion of pressure which causes rapid freezing. Hyperbaric preservation 
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allows cells to be maintained at a low temperature without freezing and in an aqueous phase 
with one study reporting that survival was a function of both compression rate and final 
pressure magnitude. Despite the deleterious effect of pressure maintenance, some tissues and 
cells shown good preservation. For example red blood cells survived pressure up to 200 MPa, 
where else liver up to 35 MPa. By increasing elevated pressure it reduces temperature to 
sub-zero Celsius [15–17]. This condition leads to rapid freezing of biological tissues, by which 
many tissues can be stored by this process, i.e., kidney (10,000 atm), cells (200 atm), and liver 
(70 atm).
7. Optimizing freezing
Freezing or cooling optimization is a big issue in cryopreservation. Optimizing freezing 
condition with cryoprotectant needs 3–4 h interventions. The slow crystal formation process 
called seeding can damage cellular integrity. Optimizing freezing rate and concentration of 
cryoprotectant are very important for long storage of cells.
If cells were cooled very slowly and steadily, then extracellular fluids of the cells form ice 
crystals which pinch the cells to withdraw all intracellular component.
At elevated −350°C temperature cells can lost its structure and shape. On the other hand, 
rapid cooling can cause serious damage to intracellular integrate of cells, where cytosol, 
parenchyma, nucleus and almost all cellular component rapidly freeze, which causes intracel-
lular formation. All the integral parts of cells may come out and cell may die due to shrinking 
[18–20].
Hence, it is important to optimize cryoprotectant concentration with cooling rate. The 
optimize cooling requires the optimum intake of cryoprotectant within the cells and main-
taining the integrity of the cells by not forming ice crystals while freezing, for example, 
human oocytes and embryos need minimum 90 min for preservation. Certain limitation of 
slow cooling makes it more challenging, such as it takes more sophisticated instruments 
with more time for cooling and at the same time certain tissues such as in vitro derived 
bovine, pig embryos, human MII oocytes, and blastocysts are very susceptible to chilling 
injuries.
7.1. Carrier solution or base perfusate used in cryoprotection
The carrier solutions acts as a life support or buffering substance for preserving cell. The main 
purpose of carrier cell is to maintain life integrity in cells during near freezing condition. 
Carrier solutions constituted with some essential buffer, osmogens, nutritional elements, salts 
and certain apoptosis inhibitors. To maintain stability within the cells, carrier solution main-
tains iso-osmolarity, which makes cells not to lose its original shape. For example M22, cryo-
protectant solution is used with specific carrier solution is called as LM5. Most importantly 
carrier solution concentration cannot be altered with altering cryoprotectant concentration. It 
should remain constant, based upon the cells to be preserve.
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7.1.1. Ice blockers
Ice blockers are the substance which prevents ice to grow. While temperature is low and pres-
sure is high this ice blocker binds with contaminants or ice inculcator to cleave ice formation. 
Examples are low molecular weight polyvinyl alcohol, polyglycerol, called as X-1000 and 
Z-1000. Mostly ice blocker is used in vitrification process.
7.2. Cryopreservation using nanosuspension
Nae-Oh Chung et al. [29], had tried to give an in-depth understanding of aggregation process 
of nanoparticles freeze-drying technique, they also outlines the importance of Cryoprotectants 
during lyophilization process. Yancai Wang et al. [30] had tried to give an outline of choos-
ing cryoprotectant in freeze dried nanosuspension with suitable functional stabilizers. 
Cryopreservation and freeze drying both are very efficient ways to improve long term stability 
of nanosuspension. In Yancai Wang et al. work, mannitol (5% w/v), trehalose (5% w/w), lac-
tose (7% w/v), sucrose (10% w/v) was considered as an optimized cryoprotectants for prepar-
ing resveratrol (RSV) and quercetin (QUE) nano suspension. During this process of preparing 
Nano suspension using anti-solvent precipitation method, d-α-tocopheryl polyethylene gly-
col succinate (TPGS) and folate modified distearoylphosphatidyl ethanolamine-polyethylene 
glycol (DSPE-PEG-FA) was used as a functional stabilizers. Upon storage for 90 days, it was 
observed that RSV & QUE nano suspension containing mannitol 5% w/v has limited devia-
tion in particle size, enhanced dissolution rate, good physical stability as compare with other 
optimized cryoprotectants containing RSV & QUE nano suspensions.
8. Recent advances in cryopreservation
Due to recent advancement of organ and tissue transplantation, it is important to have cryo-
protectants research. Roger Gosden [31] did some extensive research on preserving ovarian 
tissues. He used 0.1 M fructose and dimethyl sulfoxide (DMSO) to preserve seven rat ovaries. 
It takes over 30 min to freeze and stored in liquid nitrogen overnight before thawing. Arav 
et al. [19] develops a novel technique using 1.4 M DMSO (10% by volume) for preserving ova-
ries. This device transplanted in a test tube where freezing of organs can be possible between 
0 and −35°C. This device far end is super cooled and stable. The organs which is about to 
preserve at first must be freeze in liquid nitrogen than exposed and thawed to 68°C for 20 s 
than 37°C for 2 min. In this process preserved organ shown immediate blood perfusion after 
transplantation. Dittrich et al. [20] developed a method by freezing pig uteri in near dry ice 
temperature. It was tried to prove that this process is most efficient then vitrification technique. 
Viatcheslav Berejnov et al. [21] studied the effect of cooling rate on vitrification of aqueous 
solution. It was observed that T = 295 K to T = 77 K temperature, vitrification is reported in 
liquid nitrogen for almost all the cryopreservatives. It was concluded and confirmed that by 
X-ray crystallography, the transition from polycrystalline to vitreous occurs with in the span 
of 2% w/v in cryopreservatives. By which polycrystalline ice from hexagonal to cubic depends 
upon the elevation of cryopreservatives cooling rate and concentration. Anderson et al. [22] 
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studied about ovarian cryopreservation for fertility preservation. They concluded that oocyte 
cryopreservation technique has more advantages as it produces approximately 100 fold more 
babies as it can preserve large number of oocytes within primordial follicles without further 
hormonal therapy. Chong et al. [23] studied about cryopreservation of neurospheres which is 
derived from human glioblastoma multiforme. Cryopreservation of neurospheres cried out 
by using 90% serum and 10% dimethyl sulfoxide. Further vitrification yields self-renewal and 
multi potential properties. Xu et al. (2010) studied about the role of apoptotic pathway in the 
low recovery rate after cryopreservation of dissociated human embryonic stem cells. It was 
observed that recovery of cells after cryopreservation of human embryonic stem cells (hES) 
become a huge challenge. It was found that the generation of reactive oxygen species (ROS) 
is significantly increased with F-actin altered distribution. Further analysis shown the activa-
tion of and caspase-8 and caspase-9, which causes increase in cellular toxicity. Cetinkaya and 
Arat [24] studied about bio-banking system of cryopreservation for cartilage and tissue cells. 
Vitrification is used to preserve primary adult cartilage and fatal cartilage cells. The cartilage 
cells were slowly freeze using ethylene glycol (EG), Ficoll and sucrose. During slow cooling 
three different cooling rate were set as 0.5, 1 and 2°C/min. Results astonished all by no sig-
nificant changes in viability rations, proliferative activity and GAG synthesis observed after 
vitrification (1°C/min). This study emphasis the needs of vitrification in bio-banking of cell 
donor sources in nuclear transfer studies. Wong et al. [25] did vital studies on human embryos 
cryopreservation and its fertilization rate. In modern days cyroprotection human embryos cells 
is routine work, but optimizing success rate of transplantation is a matter of question. In this 
study high quality randomized trials were used to find best cryoprotectant protocol for fresh 
transfer of embryos. Silva et al. [26] reviewed about mammalian conservation biology and cryo-
preservation. They enlightened the importance of germ plasma cryopreservation of embryos, 
gonadal tissues, gametes, and some somatic tissues. They also dignified the importance of 
more usage of cryobanking for the preservation of cells and tissues of threatened species.
8.1. Application of cryopreservation
Now a days cryoprotectants has some versatile use. Mostly in preserving organ cells, in 
molecular biology, cryosurgery, blood transfusion, artificial insemination, bone marrow 
transplantation, in-vitro fertilization and most recently in identifying unknown transmis-
sible disease or pathogen. During 1996, first embryo preservation for fertility was took place 
using IVF cycle. IVF cycle was prerequisite before chemotherapy of breast cancer diagnosed 
patients. Preserving oocytes using cryoprotectants is already an established technique. This 
technique causes no potential side effects on parturition. Same way, sperm and semen can be 
used after proper cryopreservation. Preserving testicular gonads using cryopreservation is 
still in infancy, but in future cryopreservation can be used in vasectomy.
8.2. Limitation of cryopreservation
In cryopreservation technique, at −196°C in liquid nitrogen cells stops metabolizing which 
leads to unavoidable side effects. Sometimes there will be slow genetic changes occurs within 
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the biological cells associated with the lipids and proteins, that could disfigure integrity of the 
cells. Often it was witnessed that, cryoprotective agents could damage chromosome stability 
of cells, like in higher concentration DMSO could produce tumor and also some times cryo-
protectants makes cells susceptible towards infections.
9. Conclusion
Cryobiology will have a significant impotence in near future as a number of transplantation 
of vital organs of humans are becoming more demanding in the modern age. Yet, so many 
important complications are to be mitigated, like the exact mechanism of cryoprotectant, 
mode of action and cellular interactions with potential toxicity. More futuristic research is 
needed in respect of optimizing cryoprotectant concentration and slow and high freezing 
process. It was observed that macromolecular cells can easily preserve by cryoprotectant but 
as far as large tissues or organs (kidney, liver, heart, lungs, and skin tissues) are concerned, 
the success rate of freezing is not up to the mark by using cryoprotectant. Further optimized 
research on selection of specific concentration of cryoprotectants, freezing and thawing rates, 
best infusibility, and equilibrium times in cryopreservation might lead to better cell survival 
during preservation. Modern emerging cryobank is a promising approach towards organ 
transplantation. But still, standardization and optimization techniques are warrant for best 
cryopreservation.
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